Sensorium Therapeutics
Latest round
- Series A
Last raised
- Aug 2025
Total raised
- $41M
Investors
- 13
About Sensorium Therapeutics
Based in Massachusetts, US, and founded in 2021 by its CEO Dick Simon, and co-founders Jacob Hooker, Jerry Rosenbaum, and Steve Haggarty, Sensorium Therapeutics, Inc. operates as a biotechnology company that focuses on the research and development of medical drugs for treating mental health illnesses. In August 2025, Sensorium Therapeutics, Inc.bio, and Sante Ventures. Sensorium Therapeutics, Inc. offers a biodynamic discovery platform that leverages cutting-edge chemistry, neuroscience, and machine learning to identify, reproduce, adapt, and enhance targeted molecules and elevates their utility as modern medicines that can deliver transformational benefits to patients. In addition, the company is also developing SENS-01 as a rapid-acting and well-tolerated therapeutic for patients with anxiety and depression.
Who invested in Sensorium Therapeutics
13 investors across 2 rounds
See all investors in Sensorium Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Sensorium Therapeutics
Who invested in Sensorium Therapeutics?
Sensorium Therapeutics has 13 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sensorium Therapeutics raised?
Sensorium Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Sensorium Therapeutics last raise money?
Sensorium Therapeutics's most recent round on record is a Series A, in Aug 2025.
What does Sensorium Therapeutics do?
Based in Massachusetts, US, and founded in 2021 by its CEO Dick Simon, and co-founders Jacob Hooker, Jerry Rosenbaum, and Steve Haggarty, Sensorium Therapeutics, Inc.
Where is Sensorium Therapeutics headquartered?
Sensorium Therapeutics is headquartered in Boston, US.
Which VCs invest in companies like Sensorium Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Sensorium Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Sensorium Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.